AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27928809
Drug: Medical expulsive
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical expulsive therapy (tamsulosin 0.4 mg daily at night, furosemide 20mg, spironolactone 50mg in a single morning dose, potassium magnesium citrate 20Meq three times a day for 12 weeks)
Trial: 27928809
Drug: Medical expulsive
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical expulsive therapy
Trial: 20443801
Drug: Immediately loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediately loaded implants
Trial: 20443801
Drug: Early loaded
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early loaded implants
Trial: 20001450
Drug: Oral posaconazole
RxNorm normalized name: Posaconazole
DrugBank: Posaconazole (DB01263)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral posaconazole suspension as antifungal prophylaxis
Trial: 15599319
Drug: Everolimus 3
RxNorm normalized name: everolimus 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 3 mg/day
Trial: 15599319
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 2 g/day
Trial: 12486651
Drug: RITM (remifentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RITM (remifentanil and intrathecal morphine) anesthesia
Trial: 10433573
Drug: Antibiotic regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic regimens (ciprofloxacin, ofloxacin, norfloxacin, trimethoprim‐sulfamethoxazole, nitrofurantoin)
Trial: 10433573
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for > or = 3 days
Trial: 7725851
Drug: L-asparaginase (L-Ase)
DrugBank: Asparaginase Erwinia chrysanthemi (DB08886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-asparaginase (L-Ase) with human antithrombin III (AT III) concentrates as adjuvant treatment
Trial: 25956613
Drug: Fenofibrate 300
RxNorm normalized name: fenofibrate 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 300 mg daily
Trial: 25194004
Drug: Paricalcitol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paricalcitol (1 μg/d for 3 months, uptitrated to 2 µg/d if tolerated)
Trial: 25194004
Drug: Nonparicalcitol therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonparicalcitol therapy
Trial: 27558280
Drug: Azilsartan medoxomil
RxNorm normalized name: Azilsartan Medoxomil
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan medoxomil (AZL-M) 40 mg
Trial: 23514842
Drug: Azilsartan medoxomil
RxNorm normalized name: Azilsartan Medoxomil
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan medoxomil (AZL-M) 80 mg
Trial: 23514842
Drug: Ramipril (RAM)
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramipril (RAM) 10 mg
Trial: 17942015
Drug: Dexamphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamphetamine (10 mg) administered at the start of each session during one therapy block
Trial: 17942015
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered during the other therapy block
Trial: 19470174
Drug: Low-dose risperidone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose risperidone
Trial: 30228265
Drug: Enzyme mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme mixture containing peptidase, semi alkaline protease, deuterolysin, and cysteine protease derived from Aspergillus oryzae, Aspergillus melleus, Penicillium citrinum, and Carica papaya L.
Trial: 20200016
Drug: Episodic amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Episodic amiodarone treatment (1 month peri-cardioversion)
Trial: 18854540
Drug: Continuous amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous amiodarone treatment
Trial: 11185636
Drug: Telmisartan 120
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan 120 mg with digoxin
Trial: 1440310
Drug: Combinations of
RxNorm normalized name: Combinations of vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combinations of drugs from the first group and those from the 2nd‐4th group
Trial: 30957448
Drug: Sertraline hydrochloride
RxNorm normalized name: sertraline hydrochloride
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline hydrochloride (25 mg daily for the first 5 days, then 50 mg daily)
Trial: 18691778
Drug: Low potassium
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low potassium (<4 mEq/L)
Trial: 16522906
Drug: Placebo (control)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (control) group with 5 g rice starch
Trial: 11389298
Drug: Draft CDC
RxNorm normalized name: polyvinyl alcohol graft polyethylene glycol copolymer (3:1; 45000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Draft CDC manual entitled, 'Guideline for Vaccine Storage and Handling'
Trial: 3313757
Drug: Ibuprofen/paracetamol/codeine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen/paracetamol/codeine combination (Myprodol; Rio Ethicals) 200 mg ibuprofen, 250 mg paracetamol, 10 mg codeine phosphate per tablet
Trial: 3313757
Drug: Standard ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard ibuprofen treatment regimen (200 mg per tablet)
Trial: 31655189
Drug: Oxycodone 15
RxNorm normalized name: oxyCODONE 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 15 mg (5 mg, eight hourly)
Trial: 29480399
Drug: Resistant dextrin
RxNorm normalized name: wheat dextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant dextrin (20g daily for 3 months)
Trial: 16551916
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (single shot)
Trial: 20807664
Drug: No drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drug (control)
Trial: 16792646
Drug: Microdermabrasion (MDA)
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Microdermabrasion (MDA) in conjunction with a topical retinoid
Trial: 9228878
Drug: G II
RxNorm normalized name: mu-conotoxin G IIIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G II knee brace
Trial: 3313023
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASS) 2‐5 mg/kg
Trial: 3313023
Drug: Flunarizine 5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine 5‐10 mg
Trial: 25844615
Drug: Topical sodium
RxNorm normalized name: sodium fluoride .0176 g in 1 g / HYDROFLUORIC ACID 0.010 g in 1 g DENTAL AEROSOL, FOAM [DENTI-CARE TOPICAL SODIUM FLUORIDE STRAWBERRY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical sodium copper chlorophyllin complex (0.066%) applied twice daily for 8 weeks
Trial: 25844615
Drug: Topical sodium
RxNorm normalized name: sodium fluoride .0176 g in 1 g / HYDROFLUORIC ACID 0.010 g in 1 g DENTAL AEROSOL, FOAM [DENTI-CARE TOPICAL SODIUM FLUORIDE STRAWBERRY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical sodium copper chlorophyllin complex (0.066%)
Trial: 21945737
Drug: Intravenous ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ibandronate injection
Trial: 21945737
Drug: Intravenous ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ibandronate infusion
Trial: 16717335
Drug: Epidural ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ropivacaine (15-mL bolus, starting concentration 0.425%)
Trial: 14699020
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 alone (40 mg)
Trial: 31209595
Drug: Any anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any anticoagulant use
Trial: 28851310
Drug: Anticoagulant non-users
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant non-users
Trial: 25964404
Drug: Weekend-only recreational
RxNorm normalized name: Mountain Series Weekender Medical KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekend-only recreational drug use
Trial: 24888316
Drug: Myrtle fruit
RxNorm normalized name: Myrtle blueberry fruit
DrugBank: Bilberry (DB14235)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myrtle fruit syrup (15 ml daily for 7 days)
Trial: 1623994
Drug: Both implants
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both implants
Trial: 17571966
Drug: Wheat grass
RxNorm normalized name: Wheat grass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat grass juice (WGJ) 60 cc orally daily during the first three cycles of chemotherapy
Trial: 8790827
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of flunisolide nasal spray
Trial: 8790827
Drug: Original formulation
RxNorm normalized name: Zegerid (Original Formulation)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original formulation of flunisolide nasal spray
Trial: 3552444
Drug: Control infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control infusion
Trial: 26028346
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Ranibizumab and Bevacizumab)
Trial: 27763685
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (PTA + SEP)
Trial: 19103434
Drug: N-acetylcysteine (2400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (2400 mg daily) for 4 weeks
Trial: 19103434
Drug: Nicotine self-administration
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine self-administration or osmotic minipumps
Trial: 7951614
Drug: Triptoreline (Décapeptyl*
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptoreline (Décapeptyl* 3.75 mg)
Trial: 16386942
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (800 microg/day), B12 (20 microg/day), and B6 (4 mg/day) during 1 week (n=29)
Trial: 3530769
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg X 3 daily
Trial: 28716693
Drug: Neurodevelopmental therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurodevelopmental therapy combined with reflexology
Trial: 28716693
Drug: Neurodevelopmental therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurodevelopmental therapy alone
Trial: 15623951
Drug: Fluconazole 100
RxNorm normalized name: fluconazole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 100 mg once weekly for 12 months with topical ketoconazole cream
Trial: 15623951
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg once weekly for 12 months with topical ketoconazole cream
Trial: 15623951
Drug: Fluconazole 300
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 300 mg once weekly for 12 months with topical ketoconazole cream
Trial: 17217710
Drug: Losartan potassium
RxNorm normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan potassium 50 mg
Trial: 11273142
Drug: Enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril maleate 5 mg
Trial: 9377073
Drug: Busulfan (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Busulfan (16 mg/kg) and cyclophosphamide (120 mg/kg) (CY) in study I
Trial: 9377073
Drug: Cyclophosphamide (CY)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (CY) + TBI (200 mg/kg) + antithymocyte globulin (ATG) in study II
Trial: 3853581
Drug: Mevinolin (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mevinolin (both doses)
Trial: 3853581
Drug: Mevinolin 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mevinolin 20 mg BID
Trial: 3853581
Drug: Mevinolin 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mevinolin 10 mg BID
Trial: 25314063
Drug: No adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjuvant treatment (observation)
Trial: 18388088
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg/d increasing to 10 mg
Trial: 12453815
Drug: Community-based program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-based program to prevent drug use initiation
Trial: 1789815
Drug: Lovastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (20 mg q.p.m. for group I, 40 mg q.p.m. for group II)
Trial: 8422814
Drug: Gemfibrozil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (600 mg b.i.d.)
Trial: 26026121
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel (36 mg/m2, days 1 and 8) plus oxaliplatin (80 mg/m2, day 1)
Trial: 16356598
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate (PCV7) vaccine administered concurrently with DTaP.IPV/Hib and hepatitis B vaccines
Trial: 16356598
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate (PCV7) vaccine administered sequentially with DTaP.IPV/Hib and hepatitis B vaccines
Trial: 11772282
Drug: Trimegestone 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimegestone 0.05 mg/day
Trial: 9256568
Drug: Video-enhanced self-help
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video-enhanced self-help treatment manual
Trial: 30242825
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg nebulized salbutamol
Trial: 18173844
Drug: Lifestyle intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lifestyle intervention consisting of 3 face-to-face and 4 telephone contacts over 6 months, focusing on increasing daily physical activity, improving dietary behaviour, and smoking cessation.
Trial: 11446848
Drug: Acetyl‐L‐carnitine 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl‐L‐carnitine 1 g twice daily for 3 months
Trial: 10569556
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg twice daily for 3 months
Trial: 3052168
Drug: Propofol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.5 mg kg‐1; n = 12)
Trial: 11292011
Drug: Ayahuasca (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ayahuasca (1.0 mg DMT/kg body weight)
Trial: 6292981
Drug: d-amphetamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (20 mg)
Trial: 19780472
Drug: Once weekly
RxNorm normalized name: Actonel 35 4-Week Once Weekly Dosepack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once weekly iron supplementation (ferrous sulphate at 200 mg)
Trial: 19780472
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received once weekly vitamin C at 100 mg
Trial: 16829031
Drug: Intranasally administered
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasally administered salmon calcitonin (200 IU/day)
Trial: 14521703
Drug: 30% TCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30% TCA solution
Trial: 9382539
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion chemotherapy with CDDP + MMC +/- 5-FU (Group II)
Trial: 9382539
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion chemotherapy with radiotherapy
Trial: 8451057
Drug: Usual preoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Usual preoperative preparation provided by the physician
Trial: 3530071
Drug: Stanazolol 2
RxNorm normalized name: Stanozolol
DrugBank: Stanozolol (DB06718)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stanazolol 2 mg orally 3 times a day for 30 days
Trial: 27371264
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of DwPT vaccine after MMR
Trial: 20660848
Drug: ASD prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASD prescription optimization protocol, patient lists for long-term ASD users, financial compensation for consultations
Trial: 16298061
Drug: duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: duloxetine 60 mg QD
Trial: 16298061
Drug: duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: duloxetine 60 mg BID
Trial: 16298061
Drug: duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: duloxetine 60 mg QD or duloxetine 60 mg BID
Trial: 11881159
Drug: Combined Treatment
RxNorm normalized name: POISON IVY/OAK/SUMAC EXTRACTS COMBINED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Treatment (PE/SIT)
Trial: 31242596
Drug: Mixed spices
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed spices (5 g daily)
Trial: 17126781
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of isobaric ropivacaine (group R; n = 45)
Trial: 17126781
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg of isobaric bupivacaine (group B; n = 45)
Trial: 16510631
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (30 mg daily)
Trial: 22189527
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (30 mg daily)
Trial: 16510631
Drug: Iron and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron and zinc supplementation (30 mg each daily)
Trial: 1878534
Drug: Intravenous and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous and/or oral doses of sodium dichloroacetate (DCA)
Trial: 1878534
Drug: Oral doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral doses of sodium dichloroacetate (DCA)
Trial: 6193152
Drug: Intralesional bleomycin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional bleomycin, 1 U/ml
Trial: 15255442
Drug: Lyophilized freeze-dried
RxNorm normalized name: BLACKBERRY MESOCARP FREEZE DRIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lyophilized freeze-dried platelet derived preparation
Trial: 2810163
Drug: Ilioinguinal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilioinguinal block (0.25 ml 0.5% bupivacaine/kg)
Trial: 28494097
Drug: Dapsone 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone 1.5 mg/kg per day with methylprednisolone 0.5 mg/kg per day
Trial: 25148377
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day fluconazole for 8 days
Trial: 7676782
Drug: Eltanolone 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltanolone 0.8 mg.kg-1 (group E2)
Trial: 19767384
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin pump therapy (CSII group)
Trial: 18075301
Drug: 1E10 anti-idiotype
RxNorm normalized name: anti-CD11a
DrugBank: Efalizumab (DB00095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 1E10 anti-idiotype vaccine (1 mg of 1E10/Alum) administered via five bi-weekly injections followed by 10 doses at 28-day intervals.
Trial: 1551720
Drug: ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150 mg twice daily
Trial: 28870095
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human epidermal growth factor (rhEGF) spray
Trial: 24998106
Drug: Morphine as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine as first analgesic medication